Erythroleukemia showing early erythroid and cytogenetic responses to azacitidine therapy.
Sho
S
Hangai
Fumihiko
F
Nakamura
Yasuhiko
Y
Kamikubo
Akira
A
Honda
Shunya
S
Arai
Masahiro
M
Nakagawa
Motoshi
M
Ichikawa
Mineo
M
Kurokawa
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use*; D054316:Biomarkers, Pharmacological / Q000032:analysis / Q000378:metabolism; D020732:Cytogenetic Analysis; D041905:Erythroid Cells / Q000187:drug effects* / Q000473:pathology*; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D054316:Biomarkers, Pharmacological; D001374:Azacitidine